Navigation Links
Agilux Laboratories Announces the Launch of GLP LC/MS/MS Bioanalytical Services
Date:1/25/2010

Expanded GLP bioanalytical testing services makes Agilux the largest bioanalytical CRO in New England.

Worcester, MA (PRWEB) January 25, 2010 -- Agilux Laboratories, Inc., a Contract Research Organization (CRO) that provides bioanalytical and in vitro ADMET services for the biotechnology and pharmaceutical industries, has launched GLP compliant LC/MS/MS bioanalytical services supporting nonclinical and clinical studies.

Founded in 2007, Agilux has grown into the largest bioanalytical contract laboratory in New England by focusing on high quality, rapid turnaround services for discovery support. Agilux can now deliver the same high quality, rapid turnaround services to support GLP compliant nonclinical and clinical studies.

The "green field" start of the GLP LC/MS/MS bioanalytical service has allowed Agilux to incorporate the very latest technology with many novel, innovative approaches. The management team's extensive knowledge and experience in the GLP bioanalytical environment result in novel, efficient processes that are fully compliant with the latest regulations. With renowned customer service, Agilux is focused on delivering "Better Data Faster"

"At Agilux, we have challenged ourselves to innovate to the advantage of our clients. Our highly successful Discovery 2.0 has demonstrated that there was room to innovate in the discovery bioanalytical services space. In launching the LC/MS/MS GLP bioanalytical services, we have challenged ourselves to be as innovative as we were in discovery, without compromising outstanding compliance and customer service" said Jim Jersey, president and CEO at Agilux.

About Agilux Laboratories, Inc.

Agilux Laboratories, Inc. is a contract research organization (CRO) focused on bioanalytical and PK/PD testing services for the biotech and pharmaceutical industries. Leveraging industry and contract research experience of its management team, the company delivers high quality bioanlaytical chemistry and PK/PD data more rapidly. Agilux helps clients make better decisions during drug discovery and development by providing quality data earlier in the research process by using technologies and systems that increase turnaround speed well beyond industry standards. Founded in 2007 by industry veterans Jim Jersey, Steve Guyan and Peter Glick, Agilux is headquartered in Worcester, MA, and is funded by private equity firm Ampersand Ventures. For more information, call 508-753-5000. Online at www.agiluxlabs.com.

Contact:
Steve Guyan
Vice President, Sales and Marketing
(508)-762-4402

# # #

Read the full story at http://www.prweb.com/releases/GLPBioanalytical/AgiluxLabs/prweb3495654.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services
2. Underwriters Laboratories Announces Alternative Certification Program for Lead Free Verification of Cooking and Plumbing Products
3. Seattle-based PhenoPath Laboratories Retests Nearly 3,000 Breast Cancer Specimens from Quebec Breast Cancer Inquiry
4. Roxane Laboratories, Inc. Announces the Launch of Perindopril Erbumine Tablets
5. Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health
6. Reportlinker Adds Whos Doing What in Molecular Diagnostics? - Kalorama / Emmes Survey of US Laboratories Report
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of Directors
9. ARUP Laboratories Scientist Tanya Sandrock Receives NIH Grant to Search for Additional HIV Therapies
10. Care-Tech Laboratories Agrees to Stop Making, Selling and Distributing Unapproved Antimicrobial Products
11. Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... related services to families and business owners across eastern Michigan, is connecting with ... families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge ... now offering treatments for sleep apnea and TMJ at their office. TMJ, or ... , specifically the obstructive type, is increasingly being treated at dental offices with ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... , ... March 24, 2017 , ... “End Time GPS”: ... salient events will interrelate. “End Time GPS” is the creation of published author, ... expert while working on military munitions and space-vehicle projects. Now, at age ninety-one, he ...
(Date:3/23/2017)... , ... March 23, 2017 , ... In 2016 the ... estimates that there could be four million Zika-related cases in the Americas within the ... numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... YORK , March 24, 2017   ... leading organization within medical affairs in the pharmaceutical ... as the chair of a newly formed scientific ... board members to form the first ever medical ... For more information about the ACMA, please ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
(Date:3/24/2017)... Today Stock-Callers.com have issued research reports ... Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. ... ). These companies are part of the Healthcare sector, which ... 23 rd , 2017, with the NYSE Health Care Index ... companies in the S&P 500 were down about 0.4% as ...
Breaking Medicine Technology: